In this captivating lecture from the EASD 2022 Annual Meeting, the EASD-Lilly Centennial Anniversay prize recipient, Dr Matthias Tschöp takes us on a journey through his groundbreaking research on Ghrelin, the hunger hormone, and its impact on obesity and type 2 diabetes. From his early days at Lilly to the revolutionary development of combination therapies, Dr Tschöp shares how his work is transforming the treatment landscape.
Learn about the science behind appetite regulation, the future of metabolic disease treatments, and the challenges in developing effective therapies. This lecture provides valuable insights for researchers and clinicians alike.
#easd2022 #diabetes
